Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan G Duda

Showing results (121-130 of 261) with videos related to

Pageof 27
Sort By:
Journal of the American Chemical Society|July 8, 2015
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen SensorsChristopher M Lemon, Elizabeth Karnas, Xiaoxing Han, et al.
Oncogene|October 10, 2003
Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cellsDan G Duda, Makoto Sunamura, Liviu P Lefter, et al.
NPJ Breast Cancer|January 25, 2019
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancerVasileios Askoxylakis, Gino B Ferraro, Mark Badeaux, et al.
NPJ Precision Oncology|June 30, 2021
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patientsYves Boucher, Ashwin S Kumar, Jessica M Posada, et al.
NPJ Precision Oncology|March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancerEleni Gkika, Elke Firat, Sonja Adebahr, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with ImmunotherapyBocheng Wu, Subhasish Tapadar, Zhiping Ruan, et al.
Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Journal of the National Cancer Institute|March 15, 2022
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular CarcinomaHiroto Kikuchi, Aya Matsui, Satoru Morita, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancerPhilip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal for Immunotherapy of Cancer|May 24, 2025
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesityNilesh P Talele, Heena Kumra, Igor L Gomes-Santos, et al.
Pageof 27

Showing results (121-130 of 261) with videos related to

Sort By:
Pageof 27
Journal of the American Chemical Society|July 8, 2015
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen SensorsChristopher M Lemon, Elizabeth Karnas, Xiaoxing Han, et al.
Oncogene|October 10, 2003
Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cellsDan G Duda, Makoto Sunamura, Liviu P Lefter, et al.
NPJ Breast Cancer|January 25, 2019
Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancerVasileios Askoxylakis, Gino B Ferraro, Mark Badeaux, et al.
NPJ Precision Oncology|June 30, 2021
Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patientsYves Boucher, Ashwin S Kumar, Jessica M Posada, et al.
NPJ Precision Oncology|March 2, 2023
Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancerEleni Gkika, Elke Firat, Sonja Adebahr, et al.
Biorxiv : the Preprint Server for Biology|April 8, 2024
A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with ImmunotherapyBocheng Wu, Subhasish Tapadar, Zhiping Ruan, et al.
Journal of Neuro-Oncology|September 8, 2010
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomideElizabeth R Gerstner, April F Eichler, Scott R Plotkin, et al.
Journal of the National Cancer Institute|March 15, 2022
Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular CarcinomaHiroto Kikuchi, Aya Matsui, Satoru Morita, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancerPhilip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal for Immunotherapy of Cancer|May 24, 2025
IL-1β blockade prevents cardiotoxicity and improves the efficacy of immune checkpoint blockers and chemotherapy against pancreatic cancer in mice with obesityNilesh P Talele, Heena Kumra, Igor L Gomes-Santos, et al.
Pageof 27